Parker Geoffrey M.

CHIEF FINANCIAL OFFICERAllogene Therapeutics, Inc. (ALLO) · full profile →Form 4 · filed Mar 6, 2024
Net Buying
Open-Market Buys
$684
Open-Market Sells
$0
Net Open-Market Flow
$684
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 30, 2024Buy(P)190$3.60$684820K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001593968-24-000449) within minutes of acceptance. Every field above traces to the original document. Verify it directly: